Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol

Table 1 Adverse events diary questionnaire

Local symptoms	Pain at injection site
	Injection site swelling
	Injection site redness
	Injection site itching
	Axillary swelling and tenderness of the vaccination arm
	Other local symptoms
Systemic symptoms	Fatigue
	Headache
	Muscle ache
	Joint pain
	Chills
	Nausea/vomiting
	Diarrhea
	Fever
	Dizziness
	Other symptoms

The questionnaire can be completed either as a hard copy or electronically through RedCap and will be distributed at D0 and D60

ISSN: 1471-2334